GlassScriptPhysician profile
Ana D Karabell
NPI 1932361979
$13,529.00
in general payments reported to CMS, 2019-2025
56 companies · $2,885 in 2025
The $2,885 reported for 2025 was more than what 78% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $4,388 · 2021: $573 · 2022: $1,068 · 2023: $1,427 · 2024: $1,506 · 2025: $2,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,829 · Travel and Lodging: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,828.99 |
| Travel and Lodging | $989.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $4,128.56 | 2019-2022 | |
| Insulet Corporation | $1,768.45 | 2019-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $1,352.65 | 2019-2025 | Rybelsus, Ozempic, Sogroya |
| Abbvie INC. | $657.28 | 2019-2025 | |
| Lilly USA, LLC | $532.67 | 2019-2025 | Jardiance, Mounjaro, Trulicity |
| Sanofi-Aventis U.S. LLC | $339.48 | 2021-2025 | |
| Medtronic, INC. | $336.73 | 2022-2025 | Minimed 780g |
| Ascendis Pharma Endocrinology INC | $324.49 | 2022-2025 | Skytrofa, Yorvipath |
| Medtronic Minimed, INC. | $323.08 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $318.31 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $275.32 | 2022-2025 | Triptodur, Triptodur, Zonisade |
| Xeris Pharmaceuticals, INC. | $259.29 | 2020-2025 | Gvoke Hypopen, Recorlev, Keveyis |
| Alexion Pharmaceuticals, INC. | $215.58 | 2019-2025 | Strensiq |
| Beta Bionics, INC. | $199.58 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $199.55 | 2019-2024 | Korlym |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $173.07 | 2023-2025 | Cequr Simplicity |
| Biomarin Pharmaceutical INC. | $149.65 | 2022-2023 | Voxzogo 1.2mg |
| Kyowa Kirin, INC. | $147.43 | 2023-2025 | Crysvita |
| Sequel Med Tech, LLC | $143.27 | 2024-2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.30 | 2020-2022 | |
| Neurocrine Biosciences, INC. | $138.75 | 2025 | |
| Merck Sharp & Dohme LLC | $99.90 | 2019-2021 | |
| Horizon Therapeutics Plc | $90.83 | 2019-2022 | |
| Rhythm Pharmaceuticals, INC. | $80.03 | 2021-2025 | Imcivree, Imcivree |
| Ferring Pharmaceuticals INC. | $76.17 | 2019 | |
| Ibsa Pharma INC. | $74.31 | 2019-2023 | Tirosint, Licart |
| Pfizer INC. | $73.79 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.77 | 2022 | |
| Companion Medical, INC. | $58.16 | 2019-2020 | |
| Dexcom, INC. | $56.24 | 2019-2024 | Dexcom G6 Transmitter |
| Averitas Pharma INC. | $54.11 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $46.55 | 2021-2023 | |
| Nevro Corp. | $46.24 | 2022-2024 | Senza |
| Amneal Pharmaceuticals LLC | $44.87 | 2021-2025 | Unithroid |
| Shire North American Group INC | $42.08 | 2019 | |
| Soleno Therapeutics, INC. | $38.06 | 2025 | Vykat Xr |
| Mannkind Corporation | $36.01 | 2022-2023 | Afrezza |
| Grt US Holding, INC. | $35.62 | 2022 | |
| Endo USA, INC. | $35.10 | 2025 | Supprelin |
| Recordati_rare_diseases_inc. | $35.09 | 2022-2024 | Signifor Lar, Isturisa |
| Radius Health, INC. | $33.86 | 2025 | Tymlos |
| Takeda Pharmaceuticals U.S.A., INC. | $25.64 | 2020 | |
| Antares Pharma, INC. | $23.46 | 2025 | Xyosted |
| Optos, INC. | $23.28 | 2021 | |
| Chiesi USA, INC. | $21.15 | 2025 | Mycapssa |
| Eusa Pharma (US) LLC | $20.15 | 2022 | |
| Eton Pharmaceuticals, INC. | $19.90 | 2023 | Alkindi |
| Regeneron Healthcare Solutions, INC. | $19.85 | 2022 | |
| Amryt Pharma Holdings LTD | $19.19 | 2023 | Mycapssa |
| Tandem Diabetes Care, INC. | $19.09 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amphastar Pharmaceuticals, INC. | $16.56 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $16.07 | 2023 | Increlex, Somatuline Depot |
| Abbott Laboratories | $15.70 | 2019 | |
| Amgen INC. | $13.87 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $12.66 | 2021 | |
| Lifescan, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Karabell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.